CSL saw the highest growth of 1.17% in patent filings and 1.36% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.17% and grants by 1.36%. GlobalData’s DataBook provides a comprehensive analysis of CSL‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
CSL has been focused on protecting inventions in Australia(AU) with eight publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 18% filings and 9% grants. The World Intellectual Property Organization(WIPO), Australia(AU), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where CSL is filings its patents. Among the top granted patent authorities, CSL has 9% of its grants in Australia(AU), 9% in European Patent Office(EPO) and 5% in United States(US).
Regeneron Pharmaceuticals and Amgen could be the strongest competitors for CSL
Patents related to rare diseases and nanomedicine lead CSL's portfolio
CSL has the highest number of patents in rare diseases followed by, nanomedicine and Covid-19. For rare diseases, nearly 47% of patents were filed and no patents were granted in Q2 2024.
Graft versus host disease (gvhd) related patents lead CSL portfolio followed by myocardial infarction, and blood coagulation
CSL has highest number of patents in graft versus host disease (gvhd) followed by myocardial infarction, blood coagulation, severe acute respiratory syndrome (sars), and von willebrand disease (vwd). For graft versus host disease (gvhd), nearly 1% of patents were filed and 15% of patents were granted in Q2 2024.
For comprehensive analysis of CSL's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
